Image

SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

In a prior application (MH064372), the investigators' treatment research program (Services for Kids In Primary-care, SKIP) developed and tested a chronic care model-based intervention, called Doctor Office Collaborative Care (DOCC), that was found to be effective in the management of childhood behavior problems and comorbid ADHD. In the "SKIP for PA Study", the investigators propose to conduct a randomized clinical trial to evaluate the effects of teamand practice leadership-level implementation strategies designed to enhance the use and uptake of DOCC in diverse pediatric primary care offices.

Description

This study is a randomized, hybrid type 3 effectiveness-implementation trial to support the adoption of a chronic care model (CCM)-based intervention in pediatric primary care settings by testing the impact of implementation strategies directed towards the provider care team (TEAM) or practice leadership (LEAD) level. The treatment investigators seek to deliver here is called Doctor Office Collaborative Care (DOCC), an evidence-based intervention for the management of child behavior problems and comorbid ADHD. The implementation strategies being tested to enhance DOCC uptake include TEAM coaching/consultation strategies, which will be delivered to care team providers and target provider competency to deliver DOCC, and LEAD facilitation strategies, which will be delivered to practice leaders and target organizational support of DOCC delivery. These multi-level implementation strategies have not been formally evaluated to learn about their separate and combined effects in any randomized clinical trial conducted in pediatric primary care. Such information is needed to optimize our approaches to promoting the implementation of a CCM-based intervention in pediatric practice.

The sample includes up to 24 primary care practices from a statewide network and other networks or states. After standard training in the DOCC EBP, all practices will be randomized to one of four implementation conditions: 1) No TEAM or LEAD (ongoing technical support only); 2) TEAM implementation; 3) LEAD implementation, or 4) TEAM+LEAD implementation. TEAM and LEAD implementation will be delivered via videoconference on a graded schedule. Care teams will deliver DOCC to up to 25 children who meet a clinical cutoff for modest behavior problems and their caregivers. Investigators will collect practice/provider measures from enrolled practice staff (0, 6, 12, 18, 24 months) and caregivers over several timepoints (0, 3, 6, 12 months) to support all analyses evaluating implementation and treatment outcomes, mediation, and moderation. By proposing one of the first large pragmatic pediatric trials of a CCM-based evidence-based intervention to address these aims in response to RFA-MH-18-701 and the NIMH's Strategic Plan (4.2), this research will advance the implementation science knowledge needed to optimize promising strategies for promoting the delivery and scale-up of DOCC in a pediatric medical home.

Eligibility

The investigators propose to recruit 4 types of practice provider participants (PCP =

        primary care provider, CM = care manager, SL = Senior Leader, PM = practice manager) as
        well as caregiver participants.
        Inclusion Criteria:
          -  PCP Participants:
               -  Employed at one of the up to twenty-four (24) pediatric primary care practices
                  identified by the PA Medical Home Program at the PA AAP or by the University of
                  Pittsburgh research team.
               -  Identified by the practice as a Primary Care Provider
          -  CM Participants:
               -  Employed at one of the up to twenty-four (24) pediatric primary care practices
                  identified by the PA Medical Home Program at the PA AAP or by the University of
                  Pittsburgh research team.
               -  Identified by the practice as a Behavioral Health Resource who delivers and
                  coordinates behavioral health care in the practice, who will function in the
                  study as a care manager.
          -  SL Participants:
               -  Employed at one of the up to twenty-four (24) pediatric primary care practices
                  identified by the PA Medical Home Program at the PA AAP or by the University of
                  Pittsburgh research team.
               -  Identified by the practice as the Senior Leader.
               -  Have a practice-level leadership role such as Medical Director or a
                  clinical/practice leader
               -  Have administrative responsibilities related to patient care and/or the
                  operations/management of the practice
          -  PM Participants:
               -  Employed at one of the up to twenty-four (24) pediatric primary care practices
                  identified by the PA Medical Home Program at the PA AAP or by the University of
                  Pittsburgh research team.
               -  Identified by the practice as the Practice Manager or equivalent position
               -  Are responsible for day-to-day practice operations, such as personnel management,
                  billing, and compliance with regulations, in the pediatric practice.
          -  Caregiver Participants:
               -  Have a child age 5-12 years old who exhibits at least a modest level of behavior
                  problems (Caregiver Participants)
               -  Are at least 18 years of age (Caregiver participants)
               -  Have parental rights for this child (Caregiver participants)
        Exclusion Criteria:
          -  Caregivers
               -  Already enrolled in the study as the caregiver to a different child (e.g.,
                  sibling) (Caregiver participants)

Study details

Child Behavior Problem, Attention Deficit and Disruptive Behavior Disorders

NCT04946253

University of Pittsburgh

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.